Tudor Investment Corp’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-22,259
| Closed | -$500K | – | 1930 |
|
2024
Q3 | $500K | Buy |
22,259
+211
| +1% | +$4.74K | ﹤0.01% | 1232 |
|
2024
Q2 | $460K | Buy |
+22,048
| New | +$460K | ﹤0.01% | 1212 |
|
2024
Q1 | – | Sell |
-22,071
| Closed | -$228K | – | 1800 |
|
2023
Q4 | $228K | Buy |
+22,071
| New | +$228K | ﹤0.01% | 1313 |
|
2023
Q3 | – | Sell |
-12,991
| Closed | -$130K | – | 1795 |
|
2023
Q2 | $130K | Sell |
12,991
-9,115
| -41% | -$91.1K | ﹤0.01% | 1414 |
|
2023
Q1 | $196K | Sell |
22,106
-56
| -0.3% | -$497 | ﹤0.01% | 1383 |
|
2022
Q4 | $243K | Sell |
22,162
-35
| -0.2% | -$384 | ﹤0.01% | 1317 |
|
2022
Q3 | $289K | Buy |
22,197
+1,848
| +9% | +$24.1K | 0.01% | 1303 |
|
2022
Q2 | $258K | Sell |
20,349
-2,200
| -10% | -$27.9K | 0.01% | 1299 |
|
2022
Q1 | $316K | Sell |
22,549
-2,300
| -9% | -$32.2K | 0.01% | 1255 |
|
2021
Q4 | $719K | Buy |
+24,849
| New | +$719K | 0.01% | 1029 |
|